ADVERTISEMENT
President Donald Trump signed an executive order Saturday that he said “directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs.” A primary objective of the order is to speed treatment for veterans.
ADVERTISEMENT